NATCO launches Valsartan/Sacubitril tablet in INDIA
Deepthi | Myequity news | Date : 28-01-2019 10:45:00 IST
Natco Pharma Limited has launched Valsartan-Sacubitril tablet at an affordable price, under its brand VALSAC. Valsartan-Sacubitril is a combination drug used for certain types of heart failure, and works by relaxing blood vessels, making it easier for the heart to pump blood to the body.
NATCO has launched VALSAC in 50 mg & 100 mg strengths at an MRP of INR 45.0 and INR 55.0, per tablet, respectively.
About Natco Pharma:
Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (“FDF”) and active pharmaceutical ingredients (“APIs”). Its focus is primarily on niche therapeutic areas and complex products. It market and distribute its products in over 40 countries. It sells its FDF products in the United States, India, Europe and the rest of the world (RoW).